Studies. The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.
Studies. The clinical, pre-clinical, safety and other studies and tests conducted by or on behalf of or sponsored by Enzon or any of its Subsidiaries were and, if still pending, are being conducted in material compliance with standard medical and scientific research procedures. Neither Enzon nor any of its Subsidiaries has received any notices or other correspondence from the FDA or any other Governmental Authority requiring the termination, suspension or modification of any clinical, pre-clinical, safety or other studies or tests.
Studies. Any amounts due to the City under this pay back requirement shall be deducted from the member’s final paycheck, including any applicable vacation pay, holiday pay, sick leave, etc. The member shall make the arrangements for payment of any additional balance due with the Director of Human Resources or designee before the member’s last day of employment. The Director of Human Resources or designee will review exemptions to the repayment on a case by case basis.
Studies. The Contractor shall conduct an annual Enrollee satisfaction survey beginning six (6) months following enrollment regarding quality, availability, accessibility and satisfaction of care. A description of the methodology to be used in conducting the survey, the percentage of the Enrollees to be surveyed and other survey requirements will be provided to the Plan by the Division. To ensure comparability of results, all Enrollees will receive the same set of questions. The results of the survey and action plans derived from these results must be filed with the Division at least ninety (90) days following completion. The Contractor shall also perform a minimum of four focused studies each year on topics prevalent and significant to the population served. Due to the critical importance of the area of obesity to the Medicaid population, this area should be selected annually for study providing continuous evaluation. At least three (3) other clinical or health service delivery areas completing the required total of four (4) should be selected annually for study from the following topics: Hypertension, Diabetes, Asthma, Congestive Heart Disease, Hemophilia, and Organ Transplants. All studies are to be completed within ninety (90) days prior to the end of the contract year. The Contractor must assure the Division that QM studies are based on adverse or questionable health outcomes, quality issues affecting access to care or other QM studies related specifically to the quality of services provided. The Contractor shall maintain and make available to the Division, CMS, Office of Inspector General (OIG), the Medicaid Fraud Control Unit, and State and Federal Auditors, all studies, reports, protocols, standards, work plans, work sheets, committee minutes, committee reports to the Board of Directors, medical records, and such further documentation as may be required by the Division, concerning quality management activities and corrective actions. In addition to those set forth herein, CMS, in consultation with the State, and other stakeholders, may specify additional performance measures and topics for performance improvement projects to be undertaken by the Contractor.
Studies. After receipt by all the Owners of a valid request for large generator interconnection, NorthWestern Energy, as the designated operator, will perform the studies as set forth in its LGIP on behalf of all the Owners. Each such study will be performed pursuant to a single agreement among all the Owners and the customer. NorthWestern Energy, as the designated operator, will negotiate all applicable terms of any study agreement on behalf of the Owners.
Studies. The Council shall, to the extent it considers necessary, promote studies of the economics of cocoa production and distribution, including trends and projections, the impact of governmental measures in exporting and importing countries on the production and consumption of cocoa, the opportunities for expansion of cocoa consumption for traditional and possible new uses, and the effects of the operation of this Agreement on exporters and importers of cocoa, including their terms of trade, and may submit recommendations to members on the subject of these studies. In the promotion of these studies, the Council may co-operate with international organizations and other appropriate institutions.
Studies. Lessee acknowledges receipt of a copy of those ------- certain Phase I Environmental Site Assessment Update, Ardenwood Technology Park, 00000 Xxxxxxxxx Xxxxxxxxx, Xxxxxxx, Xxxxxxxxxx, dated September 20, 1999, prepared by ATC Associates, (Project No. 75.81075.0002) and any prior hazardous materials studies described therein ("Hazardous Substance Surveys"). The Hazardous Substance Surveys do not indicate the presence of Hazardous Materials at the leased Premises based on the present levels or content of said Hazardous Materials in the materials sampled and tested at the Building housing the Premises, as said levels or content are presently set by the U.S. Environmental Protection Agency ("EPA") or the U.S. Occupational Safety and Health Administration ("OSHA"). Lessor has no knowledge of Hazardous Materials at the Premises or in the Building but Lessor's knowledge regarding the absence of said Hazardous Materials is limited to the Hazardous Substance Surveys. For purposes of the preceding sentence, knowledge by Lessor shall be limited to the actual knowledge of the following persons: Tig Xxxxxxx. Lessor, except as provided in the following sentence of this paragraph, makes no representations or warranties whatsoever to Lessee regarding: (i) the Hazardous Substance Surveys (including, without limitation, the contents and/or accuracy thereof) or (ii) the presence or absence of toxic or Hazardous Materials in, at, or under the Premises, the Building or the Industrial Center. Lessor does acknowledge to Lessee that: (i) Lessor has not authorized any other studies for hazardous or toxic materials at the Premises or Building other than the Hazardous Substance Surveys; (ii) Lessor does not know of any surveys for toxic or Hazardous Materials at the Premises or the Building other than the Hazardous Substance Surveys; and (iii) Lessor does not know of any reason that the Hazardous Substance Surveys are not true and correct. Notwithstanding the preceding sentence, Lessee: (a) shall not rely on and Lessee hereby represents to Lessor that it has not relied on the Hazardous Substance Surveys; (b) shall make such studies and investigations, conduct such tests and surveys, and engage such specialists as Lessee deems appropriate to fairly evaluate the Premises and any risks from hazardous or toxic materials. In connection with any inspections or tests to be conducted by Lessee at the Premises or Building, Lessee shall first notify Lessor of each proposed inspection or test ...
Studies. 5.1-GEOPHYSICAL - 5.2-GEOLOGICAL - 5.3-GEOCHEMICAL: Indicate whether there is no provision for any type of geological, geophysical and geochemical study such as: AVO, Seismic Modeling, Petrophysical, Analysis of Water Depth or Testimonies, Oil Analysis, etc. If there is, it should be specified. As this is a very large item, the unit will be completed in accordance with the type of study carried out.
Studies. Buyer's approval of all soils, engineering, seismic, environmental, topography, hazardous waste, geotechnical, wetlands, drainage and other studies that may be deemed necessary by Buyer or required by any governmental agency in connection with the Property and Buyer's planned development and use of the Property.
Studies. In [2] a sequential class-based object calculus is introduced where programs consist of class definitions and a single thread definition. Considering compo- nents as sets of class definitions (and possibly a thread definition), the calculus serves as the mathematical vehicle for investigating the possible interaction traces, i.e., sequences of interactions that may take place between a component and its environment. The class-based setting makes instantiation a possible component- environment interaction which allows to create unconnected groups of objects, called cliques. Regarding a simple notion of observability, a notion of equivalence on these interaction traces is formalized which captures the uncertainty of obser- vation caused by the fact that the observer may fall into separate cliques. A similar class-based object calculus but additionally equipped with the sup- port for multi-threading and re-entrant monitors has been proposed in [4]. The idea is to capture re-entrant monitor behavior, the basic synchronization and mutex-mechanism of, e.g., multi-threaded Java. A main result is that re-entrant monitors entail additional uncertainty of observation wrt. monitor operations at the interface which are captured by may- and must-approximations for potential, respectively, necessary lock ownership. In [5] a class-based object calculus is introduced which allows dynamic thread instantiation by the support of thread classes. Similar to object instantiation, thread instantiation, occurring as a component-environment interaction, may lead to unconnected groups of objects which again increases the uncertainty of observa- tion. The work formalizes a trace semantics with a notion of observable equivalence which accounts for the observational blur due to cliques. In place of the thread-based concurrency model propagated by languages like Java and C], the work in [3] deals with object-oriented languages that introduces concurrency by means of asynchronous message passing. A corresponding object calculus is introduced capturing, furthermore, futures and promises which act as proxies for, or reference to, the delayed result from some piece of code. This allows to compare the concurrency model based on asynchronous message passing with the thread-based approach on a solid mathematical basis.